Search Tag: iCAD
2022 11 Jan
Dana Brown and Timothy Norris Irish offer extensive experience in technology, women’s breast health and unique global perspectives iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, has announced it has appointed Dana Brown and Timothy Norris Irish as new independent members of the Board...Read more
2021 30 Nov
Partnership will expand worldwide access to iCAD's full suite of breast health solutions on Arterys' fully cloud-native SaaS platform Arterys, the world's leading vendor-neutral AI platform has announced it signed a global distribution agreement with iCAD , a global medical technology leader providing innovative cancer detection and therapy...Read more
2021 30 Nov
Arterys, the world's leading vendor-neutral AI platform, today announced it signed a global distribution agreement with iCAD, a global medical technology leader providing innovative cancer detection and therapy solutions. This partnership will expand access to iCAD's industry-leading AI-powered breast health solutions via Arterys' FDA-cleared and CE-marked...Read more
2021 02 Jul
Agreement will expand access to ProFound AI and ProFound AI Risk to more facilities and imaging centers worldwide NASHUA, N.H. – June 8th, 2021 - iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it has signed a worldwide distribution agreement with Sectra,...Read more
2020 15 Jul
According to the International Agency for Research on Cancer, in 2018 breast cancer accounted for 26.4 percent of all new cancer cases in European women. [i] Europe’s radiologist shortage, particularly in Scotland and the United Kingdom, where the shortage is dire, makes it hard to maintain medical standards. [ii] Without a sufficient number...Read more
2020 19 May
“ iCAD ’s ProFound AI ™ solution has had a significant impact on our workflow. We are able to immediately react if we see something suspicious in a scan alleviating anxiety for our patients. Using the solution will allow us to expand DBT beyond diagnosis because it enables our radiologists to read as many tomosynthesis cases as we...Read more
2020 19 May
“Installing PowerLook ® Density Assessment has helped improve the workflow of our department and also in the education of our patients about the importance of knowing your breast density,” Adrea Bennett, Center for Women Supervisor, Swedish-American Hospital Summary Swedish-American Hospital (SAH), a division of UW Health,...Read more
2020 19 May
Abstract ProFound AI™ is the latest artificial intelligence algorithm developed by iCAD , Inc., Nashua, NH using deep learning technology that is intended to be used concurrently by radiologists while reading digital breast tomosynthesis (DBT) exams. The algorithm detects soft tissue densities (masses, architectural distortions and...Read more
2020 19 May
Abstract ProFound AI™ is the latest artificial intelligence algorithm developed by iCAD , Inc., Nashua, NH using deep learning technology that is intended to be used concurrently by radiologists while reading digital breast tomosynthesis (DBT) exams. The algorithm detects soft tissue densities (masses, architectural distortions and...Read more
2016 08 Mar
iCAD, Inc., a New Hampshire-based provider of advanced image analysis and workflow solutions for the early identification and treatment of cancer, announced an industry first tomosynthesis computer-aided detection (CAD) tool during the European Congress of Radiology (ECR) meeting in Vienna, Austria. The breakthrough technology employs the...Read more